Top News

Kejriwal meets boy suffering from rare genetic disorder SMA

Delhi Chief Minister Arvind Kejriwal on Tuesday met an 18-month-old boy suffering from a rare genetic disease SMA (Spinal Muscular Atrophy) to inquire about his health. The boy, Kanav, was afflicted with the genetic Spinal Muscular Atrophy (SMA) disease that affects the nerve cells that control voluntary muscles. SMA is caused by a deficiency of the SMN-1 gene in the body. 

The family had raised the funds for his treatment through crowdfunding. Mr Kejriwal said that the family had needed a Rs. 17.5 crore injection, which had to be imported from the United States. With the efforts of MPs Sanjeev Arora and Sanjay Singh and the support of the public, this injection has been administered to Kanav, he said.

“After various efforts and research, Kanav’s parents were told that there was only one cure, one injection to ameliorate Kanav’s condition which would be brought from the USA. This injection would cost a whopping Rs.17.5 crores because this is a rare disease. In the entire country, there have been only 9 such cases and this is the first case in Delhi,” Chief Minister informed on the occasion.

Mr Kejriwal said Rs 10.5 crore was raised through crowdfunding and the drug was brought from the US. “With all these valiant contributions and efforts, Kanav’s parents could accumulate Rs. 10.5 crores only. Then they called the injection company illustrating their finances and the company acknowledged that and offered the injection at Rs.10.5 crores. We want to thank the company as well”, he added.

The chief minister thanked all those who donated money, including some celebrities and MPs, for the costly injection. He also thanked the US-based drug manufacturer, saying it agreed to sell the medicine for Rs 10.5 crore. Kejriwal also thanked the Centre for exempting the medicine from import duty. After the treatment, Kanav’s situation has improved and he can sit and move his limbs, he said.

Medlarge

Recent Posts

AIIMS makes international partnership for medical research and innovation

The All India Institute of Medical Sciences (AIIMS) has signed a Memorandum of Understanding (MoU)…

17 hours ago

1 in every 3 kids to suffer from myopia by 2030 in India

As many as one-third of all urban children in India aged 5-15 years are expected…

18 hours ago

Patanjali misleading ads: SC reserves order against Baba Ramdev, asks IMA for apology

The Supreme court has reserved its order on a contempt plea against Baba Ramdev, Acharya…

2 days ago

Health claims regulated by FSSAI, but consumers must check claims with ingredients: ICMR

Although nutrition and health claims are regulated by FSSAI, consumers are advised to exercise caution…

2 days ago

ICMR warns food labels on packaged items can be misleading

The Indian Council of Medical Research (ICMR) has warned that food labels on packaged items…

3 days ago

Thalassemia: Experts calls for mandatory screening, prevention program on mission mode

Approximately 10,000 children are born with Thalassemia each year, a genetic disorder impairing the body's…

3 days ago